Vincent Rajkumar: mSMART Updated guidelines for newly diagnosed myeloma

Vincent Rajkumar shared on X:

“Just out: mSMART Updated guidelines for newly diagnosed myeloma.

Main Change: We recommend quadruplets as initial therapy for all newly diagnosed patients who are not frail. Update based on IMROZ, CEPHEUS, and BENEFIT RCT data.

We are discussing anti-CD 38 based maintenance and updates may follow in the next few months. Stay tuned. All are guidelines are available here.

Frailty and other calculators for myeloma available at myeloma.

All our guidelines are available for download as both PDF and PowerPoint. Free to use with attribution and without modification.

The website also has current guidelines for CART therapy, bispecifics, Waldenstrom Macroglobulinemia, and AL amyloidosis.”

More posts featuring Vincent Rajkumar on oncodaily.com

Vincent Rajkumar is a Professor of Medicine at the Mayo Clinic in Rochester, Minnesota, and Chair for the Mayo Clinic Myeloma, Amyloidosis, and Dysproteinemia Group.  He also chairs the Board of directors of  The International Myeloma Foundation and the Eastern Cooperative Oncology Group (ECOG) Myeloma Committee. His extensive contributions include over 230 peer-reviewed publications, predominantly focusing on multiple myeloma and related plasma cell disorders. Furthermore, Dr. Rajkumar is a Section Editor for multiple myeloma and related disorders for Leukemia and an Associate Editor for the Mayo Clinic Proceedings.